Novonesis (Novozymes A/S)
Trading by management and close relations of management
Trading by management and close relations of management
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B. The released shares relate to the 2022 legacy Chr. Hansen matching shares program and the legacy Chr. Hansen 2023 restricted stock units (RSU) program.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
BioPorto A/S4.11.2025 22:10:34 CET | Pressemeddelelse
Opdatering af forretningsstrategi – Strategien "Forward", aspirationer frem mod 2028 og finansieringsbehov
BioPorto A/S4.11.2025 22:10:34 CET | Press release
Business Strategy Update – the “Forward” Strategic Direction, Aspirations towards 2028 and Funding Needs
BioPorto A/S4.11.2025 22:08:24 CET | Pressemeddelelse
Forudgående offentliggørelse af de finansielle nøgletal for 3. kvartal 2025 og reviderede forventninger til regnskabsåret 2025
BioPorto A/S4.11.2025 22:08:24 CET | Press release
Pre-announcement of the Key Financial Results for Third Quarter 2025 and Revised Guidance for 2025
BioPorto A/S4.11.2025 22:06:49 CET | Pressemeddelelse
Statusopdatering på BioPortos kliniske studie for voksne
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom